electroCore,

electroCore, Enterprise Value

The Enterprise Value (EV) of electroCore, (ECOR) as of Oct 18, 2026 is 50.21 M USD. In the previous year, Enterprise Value (EV) was 44.58 M USD — a change of 12.62% (higher).

Enterprise Value

50.21 MUSD

YoY

12.62%

Last updated:

Enterprise Value (EV) of electroCore, is 2025 50.21 M USD. Enterprise Value (EV) of electroCore, was 2024 44.58 M USD. It decreases by 12.62% higher compared to the previous year.

The electroCore, Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
-16.15 M USD
Jan 1, 2019
30.37 M USD
Jan 1, 2020
32.61 M USD
Jan 1, 2021
18.49 M USD
Jan 1, 2022
35.40 M USD
Jan 1, 2023
42.71 M USD
Jan 1, 2024
44.58 M USD
Jan 1, 2025
50.21 M USD
The electroCore, Enterprise Value history
YEAREnterprise ValueYoY
50.21 MUSD+12.62%
44.58 MUSD+4.38%
42.71 MUSD+20.64%
35.40 MUSD+91.51%
18.49 MUSD-43.32%
32.61 MUSD+7.38%
30.37 MUSD-288.06%
-16.15 MUSD-205.98%
15.24 MUSD-74.32%
59.33 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Enterprise Value (EV) of electroCore, is 50.21 M USD in 2025.

Enterprise Value (EV) of electroCore, changed from 44.58 M USD to 50.21 M USD, representing a 12.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) electroCore, since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s electroCore, with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — electroCore,

All Key Metrics — electroCore,